Brief: Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results
03/03/2025 21:59
March 3 (Reuters) - Ekso Bionics Holdings Inc EKSO.O: EKSO BIONICS Q4 INCOME FROM OPERATIONS USD -2.23 MILLION EKSO BIONICS Q4 NET INCOME USD -3.413 MILLION EKSO BIONICS Q4 OPERATING EXPENSES USD 4.944 MILLION EKSO BIONICS Q4 GROSS PROFIT USD 2.714 MILLION EKSO BIONICS Q4 REVENUE USD 5.09 MILLION EKSO BIONICS HOLDINGS INC - Q4 LOSS PER SHARE $0.14 Source text: ID:nGNX594g2V Further company coverage: EKSO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chronoscale
See all newsBrief: Soluna To Form Strategic Partnership With Applied Digital For Wind-Powered AI Data Center In Texas
Brief: Chronoscale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue To $1 Billion And Sale Of Ekso Bionics Business Unit
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
U.S. STOCKS ON THE MOVE-Veeva Systems, Dollar General, ChronoScale